Analysts expect Zogenix, Inc. (NASDAQ:ZGNX) to report $-0.74 EPS on May, 3.They anticipate $0.11 EPS change or 12.94% from last quarter’s $-0.85 EPS. After having $-1.14 EPS previously, Zogenix, Inc.’s analysts see -35.09% EPS growth. The stock decreased 0.38% or $0.15 during the last trading session, reaching $39.8. About 17,175 shares traded. Zogenix, Inc. (NASDAQ:ZGNX) has risen 253.21% since April 24, 2017 and is uptrending. It has outperformed by 241.66% the S&P500.
Fortune Brands Home & Security Inc (FBHS) investors sentiment increased to 1.41 in Q4 2017. It’s up 0.43, from 0.98 in 2017Q3. The ratio increased, as 217 investment managers started new or increased positions, while 154 cut down and sold stock positions in Fortune Brands Home & Security Inc. The investment managers in our database now own: 127.08 million shares, up from 124.72 million shares in 2017Q3. Also, the number of investment managers holding Fortune Brands Home & Security Inc in top ten positions decreased from 4 to 2 for a decrease of 2. Sold All: 18 Reduced: 136 Increased: 145 New Position: 72.
Fortune Brands Home & Security, Inc. provides home and security products for use in residential home repair, remodeling, new construction, and security applications. The company has market cap of $8.27 billion. It operates in four divisions: Cabinets, Plumbing, Doors, and Security. It has a 18.42 P/E ratio. The Cabinets segment makes custom, semi-custom, and stock cabinetry, as well as vanities for the kitchen, bath, and other parts of the home directly to kitchen and bath dealers, home centers, wholesalers, and builders in North America.
Since January 1, 0001, it had 0 insider buys, and 3 insider sales for $6.35 million activity.
The stock decreased 2.41% or $1.38 during the last trading session, reaching $55.88. About 384,511 shares traded. Fortune Brands Home & Security, Inc. (FBHS) has declined 3.33% since April 24, 2017 and is downtrending. It has underperformed by 14.88% the S&P500.
Ratings analysis reveals 56% of Fortune Brands Home & Security’s analysts are positive. Out of 9 Wall Street analysts rating Fortune Brands Home & Security, 5 give it “Buy”, 0 “Sell” rating, while 4 recommend “Hold”. The lowest target is $59.0 while the high is $70.0. The stock’s average target of $65 is 16.32% above today’s ($55.88) share price. FBHS was included in 9 notes of analysts from September 1, 2016. RBC Capital Markets maintained the shares of FBHS in report on Thursday, October 27 with “Outperform” rating. As per Friday, September 23, the company rating was initiated by Bank of America. Wells Fargo initiated Fortune Brands Home & Security, Inc. (NYSE:FBHS) on Thursday, September 29 with “Outperform” rating. The firm earned “Equal Weight” rating on Friday, January 6 by Barclays Capital. The rating was downgraded by Goldman Sachs on Monday, December 12 to “Neutral”. The stock of Fortune Brands Home & Security, Inc. (NYSE:FBHS) earned “Buy” rating by Longbow on Thursday, April 6. The firm has “Neutral” rating given on Thursday, September 1 by Citigroup. The company was downgraded on Tuesday, October 18 by KeyBanc Capital Markets. JP Morgan upgraded the shares of FBHS in report on Monday, October 31 to “Overweight” rating.
Analysts await Fortune Brands Home & Security, Inc. (NYSE:FBHS) to report earnings on April, 26 after the close. They expect $0.59 earnings per share, up 11.32% or $0.06 from last year’s $0.53 per share. FBHS’s profit will be $87.33M for 23.68 P/E if the $0.59 EPS becomes a reality. After $0.80 actual earnings per share reported by Fortune Brands Home & Security, Inc. for the previous quarter, Wall Street now forecasts -26.25% negative EPS growth.
Crystal Rock Capital Management holds 3.71% of its portfolio in Fortune Brands Home & Security, Inc. for 84,171 shares. Premier Asset Management Llc owns 212,885 shares or 3.25% of their US portfolio. Moreover, Chilton Investment Co Llc has 2.6% invested in the company for 985,097 shares. The Arkansas-based Greenwood Gearhart Inc has invested 2.37% in the stock. Valicenti Advisory Services Inc, a New York-based fund reported 69,090 shares.
Zogenix, Inc., a pharmaceutical company, develops and commercializes therapies for the treatment of central nervous system disorders in the United States. The company has market cap of $1.39 billion. The company's lead product candidate is the ZX008, a low-dose fenfluramine, which is in Phase III clinical trials for the treatment of seizures associated with Dravet syndrome. It currently has negative earnings. It also develops Relday, an injectable formulation of risperidone to treat the symptoms of schizophrenia and bipolar disorder in adults and teenagers with 13 years of age and older.
Among 7 analysts covering Zogenix (NASDAQ:ZGNX), 7 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Zogenix had 16 analyst reports since August 6, 2015 according to SRatingsIntel. The rating was maintained by Stifel Nicolaus on Thursday, September 21 with “Buy”. Leerink Swann maintained it with “Outperform” rating and $54 target in Friday, February 23 report. The stock of Zogenix, Inc. (NASDAQ:ZGNX) has “Buy” rating given on Friday, September 29 by William Blair. The stock has “Buy” rating by JMP Securities on Monday, November 27. As per Monday, June 26, the company rating was maintained by Stifel Nicolaus. The rating was maintained by Brean Capital with “Buy” on Friday, August 14. The stock of Zogenix, Inc. (NASDAQ:ZGNX) earned “Hold” rating by Zacks on Saturday, August 15. The stock of Zogenix, Inc. (NASDAQ:ZGNX) earned “Buy” rating by Stifel Nicolaus on Friday, September 29. The stock of Zogenix, Inc. (NASDAQ:ZGNX) earned “Buy” rating by Brean Capital on Thursday, September 17. Leerink Swann maintained the stock with “Outperform” rating in Tuesday, August 11 report.